DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will participate on a panel at the C21 BioVentures Conference in Napa, Ca titled “Structured Acquisitions: Win-Win or Lose-Lose?”
News | 04. 08. 2009
